The Food and Drug Administration (FDA) has granted Fast Track designation to PP-01 (nabilone/gabapentin) for the mitigation of cannabis withdrawal symptoms in patients with cannabis use disorder.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback